FDA approves new drugs for diabetes
On Sept. 25, the U.S. Food and Drug Administration (FDA) approved Tresiba (insulin degludec injection) and Ryzodeg 70/30 (insulin degludec/insulin aspart injection) to improve glucose control in adults…
Please share your feedback! We’re interested to learn more about your experience with American Nurse Journal.